Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04464226 |
|---|---|
| Brief Title: | Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer |
| First Submitted : | July 7, 2020 |
| First Submitted that Met QC Criteria : | July 7, 2020 |
| First Posted : | July 9, 2020 |
| Last Update Submitted that Met QC Criteria : | April 12, 2021 |
| Last Update Posted : | April 14, 2021 |